昇華蘭德(08106.HK)擬委任徐寅為執行董事
格隆匯3月21日丨昇華蘭德(08106.HK)公吿,戚金松因須要投入更多的時間及專注於其他商業事務,已提出辭任執行董事、董事長、公司薪酬委員會委員及提名委員會委員職位。戚的辭任自2022年3月31日起生效。
董事會建議委任徐寅為第八屆董事會執行董事,任期自股東於股東周年大會批准日起至屆董事會任期屆滿日止。
董事會進一步宣佈,盧偉鋒因工作調整的原因,提出辭任公司監事及監事會主席職位。盧的辭任自2022年3月31日起生效。監事會建議委任宋志偉為第八屆監事會監事,任期自股東於股東周年大會上批准日起至屆監事會任期屆滿日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.